• Technology Underpins Positive Performance

News & Views

Technology Underpins Positive Performance

May 13 2015

Reporting highlights for the first quarter of 2015, Thermo Fisher Scientific announced increased adjusted earnings per share (EPS) by 7% to $1.63 and increased revenue to $3.92 billion. Adjusted operating margin expanded by 60 basis points to 21.9%.

New products, highlighted by the Gemini handheld chemical analyser, Q Exactive Focus mass spectrometer and the latest release of Sample Manager LIMS all launched at Pittcon, as well as the new PDM3700 personal coal dust monitor, TSX ultralow-temperature freezer and the Ion Torrent AmpliSeq RNA Fusion panel demonstrate current strengths in technology which underlying the company’s success

Better penetration of analytical instrument markets in Asia had been achieved through the acquisition of two channel partners covering Singapore, Malaysia and South Korea and the purchase of Advanced Scientifics, Inc. (ASI) for $300 million, added complementary single-use systems and bioprocess equipment to a portfolio  providing customers with greater flexibility in vaccine and biotherapeutic drug production.

“We’re pleased to have delivered solid adjusted EPS growth in the quarter, which demonstrates how well our team navigated the challenging foreign exchange environment,” said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific.

“We’re off to a terrific start in technology innovation, with new analytical instruments and software for customers in applied markets, as well as a personal dust monitor to improve miner safety, the European launch of a high-efficiency laboratory freezer and a new gene-sequencing panel for lung cancer research.

We also continued to make excellent progress in emerging markets, delivering strong results in China, South Korea and India, and increasing our direct commercial presence in Asia.

In addition, we deployed $800 million of capital to strengthen our strategic position and create shareholder value, expanding our bioproduction offering by acquiring ASI and buying back our stock early in the year.”


Digital Edition

Lab Asia 31.4 August 2024

August 2024

Chromatography Articles - HPLC gradient validation using non-invasive flowmeters Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers   Labo...

View all digital editions

Events

Thailand Lab 2024

Sep 11 2024 Bangkok, Thailand

Bio Asia Pacific 2024

Sep 11 2024 Bangkok, Thailand

Medical Fair Asia 2024

Sep 11 2024 Singapore

ILMAC

Sep 18 2024 Lausanne, Switzerland

ICIF China 2024

Sep 19 2024 Shanghai, China

View all events